serum and glucocorticoid-regulated kinase-1 inhibitors (Visionary)

N/A

Report date: 2025/01/26 17:51:27
NME

Base Information

Drug Nameserum and glucocorticoid-regulated kinase-1 inhibitors (Visionary)
Drug Alias NameSC-361201
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerine/threonine-protein kinase Sgk1 inhibitors
TargetsSerine/threonine-protein kinase Sgk1
Therapy Area/IndicationsMetastatic breast cancerTriple Negative Breast NeoplasmsThyroid Carcinoma, Anaplastic +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesVisionary Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesVisionary Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsMetastatic breast cancerTriple Negative Breast NeoplasmsThyroid Carcinoma, Anaplastic
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A